Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Cosmetics
News & Events
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Our Role
Safety Information
Regulatory Information
News & Events
Special Topics
Controlled Substances
Blood, Tissues, Organs
HPRA working at EU level to remove/reduce MI in cosmetics
News Category:
Regulatory news
Date:
29/04/2015
The HPRA states that whilst the vast majority of consumers won’t have sensitivity to Methylisothiazolinone (MI) it is concerned about increased sensitivity to MI overall. The HPRA, in tandem with our colleagues across the other EU Member States, has been and is currently working with the European Commission on new laws to reduce the amount of MI permitted in cosmetic products.
HPRA Statement on Methylisothiazolinone
« Back
Date Printed: 20/04/2024